Published in AIDS Weekly, October 11th, 1999
Now an analysis of data from a clinical trial in children on highly active antiretroviral treatments (HAART) has shown that such children tend to have higher viral loads before starting treatment - and that even if viral loads could be reduced to very low levels, weight and height growth do not rebound as had been hoped.
This means that additional treatments or interventions beyond antiretroviral therapy may be needed in HIV infected children with impaired growth.
The results are drawn from data collected in Pediatric Aids Clinical Trials Group Protocol 338 (PACTG...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.